pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Cedars-Sinai Medical Center

updated 5mo ago

Cedars-Sinai Medical Center is a 919-bed teaching hospital and research center in Los Angeles, California.

community read0 votes

🐶 often sniffed alongside

top 2
  • tagHepatology1 co-mentions · 1 sources
  • tagInfectious Disease1 co-mentions · 1 sources
pipeline
2
marketed
0
phase 3
0
catalysts ytd
5
approvals ytd
0
recalls ytd
0

Pipeline(2)

pipeline depth2 products
Preclinical: 1Phase 2: 1
1Preclinical1Phase 2
Phase 2
CNS10-NPC
Amyotrophic Lateral Sclerosis
Preclinical
Gene Therapy for Bone Fracture
Bone Fracture

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancerrecruitingn=34
  • phase2SAMe in Prevention of Oxaliplatin-associated Liver Injurynot yet recruitingn=30
  • phase1Atezolizumab for Idiopathic Pulmonary Fibrosisactive not recruitingn=24
  • N/ACHOICE to AVOID or RESISTnot yet recruitingn=60
  • N/AAvoid and Resist Strategies for Weight Managementrecruitingn=503
  • N/AProactive Costs of Care Studyrecruitingn=36
  • —A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancerrecruitingn=900
  • —A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Canceractive not recruitingn=450
🐶 Hiring Signal
No open roles indexed yet — view Cedars-Sinai Medical Center jobs →

News

  • Webinar: Optimizing Cell Therapy Manufacturing Efficiency with Cryopreserved Cells
    In this webinar, we will show how delayed isolation and cryopreservation of immune cells from fresh leukopaks can drastically impact their stability and functionality. We will also explore how puri…
    biospace · 4d ago
  • Kairos seizes moment to push prostate cancer prospect into earlier setting
    Kairos Pharma is moving prostate cancer prospect ENV-105 into an earlier line of treatment in response to midphase survival data.
    fiercebiotech · 1mo ago
identifiers
source
globaldata
top tags
ALS1
mentioned in
2news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?